Changjing Cai
- Molecular Biology
- Cancer Research top 5%
- Oncology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Immunology
- Topics
- Ferroptosis and cancer prognosis (12 papers)Epigenetics and DNA Methylation (10 papers)RNA modifications and cancer (9 papers)
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Changjing Cai
49 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Molecular Biology 634
- Cancer Research 371
- Oncology 362
- Pulmonary and Respiratory Medicine 227
- Immunology 143
Countries citing papers authored by Changjing Cai
This map shows the geographic impact of Changjing Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changjing Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changjing Cai more than expected).
Fields of papers citing papers by Changjing Cai
This network shows the impact of papers produced by Changjing Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changjing Cai. The network helps show where Changjing Cai may publish in the future.
Co-authorship network of co-authors of Changjing Cai
This figure shows the co-authorship network connecting the top 25 collaborators of Changjing Cai. A scholar is included among the top collaborators of Changjing Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changjing Cai. Changjing Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 4 | |
| 3 | 5 | |
| 4 | 5 | |
| 5 | 1 | |
| 6 | Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapybreakdown → | 30 |
| 7 | 0 | |
| 8 | 3 | |
| 9 | 3 | |
| 10 | 23 | |
| 11 | 13 | |
| 12 | 8 | |
| 13 | 16 | |
| 14 | 6 | |
| 15 | 25 | |
| 16 | 30 | |
| 17 | 23 | |
| 18 | 40 | |
| 19 | 48 | |
| 20 | 67 |
About Changjing Cai
Changjing Cai is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 52 papers that have together received 1.2k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (12 papers), Epigenetics and DNA Methylation (10 papers) and RNA modifications and cancer (9 papers). The work is most often cited by research in Cancer Research (371 citations), Oncology (362 citations) and Molecular Biology (634 citations). Changjing Cai has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Hong Shen, Ying Han, Shan Zeng, Cao Guo, Yihan Liu, Ganlu Deng, Yihong Chen, Wantao Wu, Hao Zhang and Ling Yin. Their work appears in journals such as Hepatology, Scientific Reports and Journal of Cell Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.